Regenerative Medical Technology (RMTG) Accumulated Depreciation & Amortization (2018 - 2025)
Historic Accumulated Depreciation & Amortization for Regenerative Medical Technology (RMTG) over the last 8 years, with Q3 2025 value amounting to $161536.0.
- Regenerative Medical Technology's Accumulated Depreciation & Amortization fell 4657.51% to $161536.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $161536.0, marking a year-over-year decrease of 4657.51%. This contributed to the annual value of $250164.0 for FY2024, which is 7626.74% up from last year.
- Per Regenerative Medical Technology's latest filing, its Accumulated Depreciation & Amortization stood at $161536.0 for Q3 2025, which was down 4657.51% from $232728.0 recorded in Q2 2025.
- Regenerative Medical Technology's Accumulated Depreciation & Amortization's 5-year high stood at $302361.0 during Q3 2024, with a 5-year trough of -$198418.0 in Q1 2024.
- Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $46461.0 (2022), whereas its average is $74096.6.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first soared by 666833.33% in 2021, then crashed by 71538.32% in 2024.
- Over the past 5 years, Regenerative Medical Technology's Accumulated Depreciation & Amortization (Quarter) stood at $43536.0 in 2021, then rose by 26.79% to $55199.0 in 2022, then surged by 157.11% to $141923.0 in 2023, then skyrocketed by 76.27% to $250164.0 in 2024, then tumbled by 35.43% to $161536.0 in 2025.
- Its Accumulated Depreciation & Amortization stands at $161536.0 for Q3 2025, versus $232728.0 for Q2 2025 and $277593.0 for Q1 2025.